Heterogeneous p53 mutations in a Burkitt lymphoma from an AIDS patient with monoclonal c-myc and VDJ rearrangements

International Journal of Cancer

Volumn 73, Issue 6, 1997, Pages 816-821

  Campomenosi, Paola ^a   Fronza, Gilberto ^a   Ottaggio, Laura ^a   Roncella, Silvio ^a   Inga, Alberto ^a   Bogliolo, Massimo ^a   Monti, Paola ^a   Assereto, Paola ^a   Moro, Francesca ^a   Cutrona, Giovanna ^a   Bozzo, Simonetta ^a   Chiorazzi, Nicholas ^c   Abbondandolo, Angelo ^a,b   Ferrarini, Manlio ^a,b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; BURKITT LYMPHOMA; CELL CULTURE; CHROMOSOME DELETION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE REARRANGEMENT; GENETICS; HETEROZYGOTE; HUMAN; IMMUNOGLOBULIN GENE; METABOLISM; ONCOGENE MYC; TUMOR SUPPRESSOR GENE;

B-LYMPHOCYTES; BURKITT LYMPHOMA; CHROMOSOME DELETION; FEMALE; GENE REARRANGEMENT; GENES, IMMUNOGLOBULIN; GENES, MYC; GENES, P53; HETEROZYGOTE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOMA, AIDS-RELATED; TUMOR CELLS, CULTURED;

EID: 0031564216     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19971210)73:6<816::AID-IJC8>3.0.CO;2-5     Document Type: Article

References (20)

1. BANCHEREAU, J., BAZAN, F., BLANCHARD, D., BRIÉRE, F., GALIZZI, J.P., VAN KOOTEN, C., LIU, Y.J., ROUSSET, F. and SAELAND, S., The CD40 antigen and its ligand. Ann. Rev. Immunol., 12, 881-922 (1994).
2. BATANIAN, J.R., LEDBETTER, S.A., WOLFF, R.K., NAKAMURA, Y., WHITE, R., DOBYNS, W.B. and LEDBETTER, D.H., Rapid diagnosis of Miller-Dicker syndrome and isolated lissencephaly sequence by the polymerase chain reaction. Hum. Genet., 85, 555-559 (1990).
3. CLORE, G.M., OMICHINSKI, J.G., SAKAGUCHI, K., ZAMBRANO, N., SAKAMOTO, H., APHELLA, E. and GRONENBORN, A.M., High-resolution structure of the oligomerization domain of p53 by multidimensional NMR. Science, 265, 386-391 (1994).
4. CUTRONA, G., ULIVI, M., FAIS, F., RONCELLA, S. and FERRARINI, M., Transfection of the c-myc oncogene into normal Epstein-Barr virus-harbouring B cells results in new phenotypic and functional features resembling those of Burkitt lymphoma cells and normal centroblasts. J. exp. Med., 181, 699-711 (1995).
5. D'AGOSTINI, F., FRONZA, G., CAMPOMENOSI, P., IZZOTTI, A., PETRILLI, G.L., ABBONDANDOLO, A. and DE FLORA, S., Cancer biomarkers in human atherosclerotic lesions. No evidence of p53 involvement. Cancer Epidemiol Prev., 4, 111-115 (1995).
6. FLAMAN, J.M. and 13 OTHERS, Simple p53 functional assay for screening cell lines, blood, and tumors. Proc. nat. Acad. Sci. (Wash.), 92, 3963-3967 (1995).
7. GAIDANO, G. and DALLA-FAVERA, R., Molecular pathogenesis of AIDS-related lymphoma. Adv. Cancer Res., 67, 113-153 (1995).
8. HALUSKA, F.G., TSUJIMOTO, Y. and CROCE, C.M., Oncogene activation by chromosome translocation in human malignancy. Ann. Rev. Genet., 21, 321-345 (1987).
9. HSU, B., MARIN, M.C., EL-NAGGAR, A.K., STEPHENS, L.C., BRISBAY, S. and MCDONNELL, T.J., Evidence that c-myc mediated apoptosis does not require wild type p53 during lymphomagenesis. Oncogene, 11, 175-179 (1995).
10. JAIN, R., RONCELLA, S., HASHIMOTO, S., CARBONE, A., FRANCIA DI CELLE, P., FOÁ, R., FERRARINI, M. and CHIORAZZI, N., A potential role for antigen selection in the clonal evolution of Burkitt's lymphoma. J. Immunol. 153, 45-52 (1994).
11. LIEBERMAN, D.A., HOFFMAN, B. and STEINMAN, R.A., Molecular controls of growth arrest and apoptosis: p53-dependent and p53 independent pathways. Oncogene, 11, 199-210 (1995).
12. MAGRATH, I., The pathogenesis of Burkitt's lymphoma. Adv. Cancer Res., 55, 133-270 (1990).
13. MULLER, J., JANZ, S., GOEDERT, J.J., POTTER, M. and RABKIN, C.S., Persistence of immunoglobulin heavy chain/c-myc recombination-positive lymphocyte clones in the blood of human immunodeficiency virus-infected homosexual men. Proc. nat. Acad. Sci. (Wash.), 92, 6577-6581 (1995).
14. PELED, A., ZIPORI, D. and ROTTER, V., Cooperation between p53-dependent and p53-independent apoptotic pathways in myeloid cells. Cancer Res., 53, 2148-2156 (1996).
15. PINKEL, D., STRAUME, T. and GRAY, J.W., Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. Proc. nat. Acad. Sci. (Wash.), 83, 2934-2938 (1986).
16. PROKOCIMER, M. and ROTTER, V., Structure and function of the p53 in normal cells and their aberrations in cancer cells: projection on the haematology cell lineages. Blood, 84, 2391-2411 (1994).
17. RAMQVIST, T., MAGNUSSON, K.P., WANG, Y., SZEKELY, L., KLEIN, G. and WIMAN, K.G., Wild-type p53 induces apoptosis in a Burkitt lymphoma (BL) line that carries mutant p53. Oncogene, 8, 1495-1500 (1993).
18. RONCELLA, S., CUTRONA, G., FAVRE, A., ULIVI, M., FAIS, F., SIGNORINI, A., GROSSI, C.E., CHIORAZZI, N. and FERRARINI, M., Apoptosis of Burkitt's lymphoma cells induced by specific interaction of surface IgM with a self-antigen. Implications for lymphomagenesis in AIDS. Blood, 88, 599-608 (1996).
19. ROY, B., BEAMON, J., BALINT, E. and REISMAN, D., Transactivation of the human p53 tumor suppressor gene by c-Myc/Max contributes to elevated mutant p53 expression in some tumors. Mol. cell. biol., 14, 7805-7815 (1994).
20. SHIRAMIZU, B., BARRIGA, F., NEEQUAYL, J., AYESHA, J., DALLA-FAVERA, R., NERI, A., GUTTIEREZ, M., LEVINE, P. and MAGRATH, I., Patterns of chromosomal breakpoint locations in Burkitt's lymphoma: relevance to geography and Epstein-Barr virus association. Blood, 77, 1516-1526 (1991).